Strategy for CYP3A Induction Risk Assessment from Preclinical Signal to Human: a Case Example of a Late-Stage Discovery Compound.
about
Strategy for CYP3A Induction Risk Assessment from Preclinical Signal to Human: a Case Example of a Late-Stage Discovery Compound.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Strategy for CYP3A Induction R ...... Late-Stage Discovery Compound.
@en
type
label
Strategy for CYP3A Induction R ...... Late-Stage Discovery Compound.
@en
prefLabel
Strategy for CYP3A Induction R ...... Late-Stage Discovery Compound.
@en
P2093
P2860
P1476
Strategy for CYP3A Induction R ...... Late-Stage Discovery Compound
@en
P2093
Brian Dean
Cornelis E C A Hop
Jianshuang Wang
Matthew Wright
Moulay Hicham Alaoui Ismaili
Susan Wong
P2860
P304
P356
10.1007/S11095-017-2246-8
P50
P577
2017-08-16T00:00:00Z